' Revolutionary' Data to Be Presented at ESMO 2018'Revolutionary' Data to Be Presented at ESMO 2018
Evolutions and even revolutions are expected when the latest data in head and neck cancer, renal cell carcinoma, breast cancer, and ovarian cancer are presented at the leading European cancer meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Head and Neck Cancer | Medscape Head and Neck Cancer | Medscape
Head and neck cancer, which includes cancers of the larynx, nasal passages, oral cavity, pharynx, salivary glands, and thyroid, accounts for 3% of all malignancies in the United States. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

The royal fern shown to be effective in treating head and neck cancers
(Natural News) Head and neck cancers account for only four percent of all cancer cases in the U.S., making it a rare form of the disease. However, for something so uncommon, it has a shockingly disturbing survival rate of only 27 percent. This type of cancer is diagnosed more often among people over the age of 50;... (Source: NaturalNews.com)
Source: NaturalNews.com - October 6, 2018 Category: Consumer Health News Source Type: news

Physician experts highlight research ahead of Otolaryngology's Annual Meeting
(American Academy of Otolaryngology - Head and Neck Surgery) The latest research on ear health, head and neck cancer, sleep-disordered breathing, rhinology and allergy, facial plastics, laryngology and swallowing disorders, endocrine surgery, and other topics related to otolaryngology-head and neck surgery will be presented in Atlanta, Ga., October 7-10, during the 2018 Annual Meeting& OTO Experience of the American Academy of Otolaryngology-Head and Neck Surgery Foundation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2018 Category: International Medicine & Public Health Source Type: news

HPV-related cancer treatment gets boost from new shot
University of Pennsylvania researchers have discovered that an shot activates patients' immune systems so they can fight even late stage HPV-related head and neck cancers, a study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2018 Category: Consumer Health News Source Type: news

DNA vaccine leads to immune responses in HPV-related head and neck cancer
(University of Pennsylvania School of Medicine) A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of Pennsylvania tested the immunotherapy approach in two groups of patients with advanced head and neck squamous cell carcinoma (HNSCCa) and found 86 percent showed elevated T cell activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2018 Category: Cancer & Oncology Source Type: news

Enhancing Cancer Immunotherapy with Artificial Intelligence
Physicians may soon use artificial intelligence (AI) and medical images to study tumors without a biopsy. The techniques developed to study tumors in this new way are described in the September 1 issue of The Lancet Oncology. Along with helping physicians learn more about tumors without surgery, the new approach should help identify which cancer patients will respond best to cutting-edge immunotherapy treatments. The AI techniques could be useful for “predicting clinical outcomes of patients treated with immunotherapy when validated by further prospective randomized trials,” the authors wrote. Immunotherapy tre...
Source: Asbestos and Mesothelioma News - September 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Galera Therapeutics raises $150 million in largest-ever Series C raise by a St. Louis bioscience company
Clinical-stage drug discovery company Galera Therapeutics has raised $150 million in a Series C financing and royalty purchase agreement. According to a release, it is the largest ever Series C raise by a St. Louis bioscience company. Led by Clarus, proceeds from the raise will be used for the clinical development of the drug GC4419, which has shown to reduce the incidence and duration of severe oral mucositis, a side effect of radiation treatment in head and neck cancer patients that causes painful… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 19, 2018 Category: Health Management Authors: Vince Brennan Source Type: news

Galera Therapeutics raises $150 million in largest-ever Series C raise by a St. Louis bioscience company
Clinical-stage drug discovery company Galera Therapeutics has raised $150 million in a Series C financing and royalty purchase agreement. According to a release, it is the largest ever Series C raise by a St. Louis bioscience company. Led by Clarus, proceeds from the raise will be used for the clinical development of the drug GC4419, which has shown to reduce the incidence and duration of severe oral mucositis, a side effect of radiation treatment in head and neck cancer patients that causes painful… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2018 Category: Biotechnology Authors: Vince Brennan Source Type: news

Scientists map interactions between head and neck cancer and HPV virus
(Gladstone Institutes) A team of scientists led by Nevan   J. Krogan,   PhD, senior investigator at the Gladstone Institutes, mapped the interactions between all HPV proteins and human proteins for the first time. Their findings are published today in the journal Cancer Discovery. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 12, 2018 Category: Infectious Diseases Source Type: news

Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
The ENTity™ XL Nasopharyngoscope has been selected by the leading health care provider as the preferred choice in technology utilized to diagnose and manage patients with head and neck cancers. STURBRIDGE, Mass., Sept. 7, 2018 -- (Healthcare Sales & Mar... Devices, Oncology Optim LLC, ENTityXL, Nasopharyngoscope, FreedomView, OptiLux (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Alpha Tau Medical raises $29m
Alpha Tau Medical said today it raised $29 million in a private funding round to help support its alpha radiation cancer therapy technology. The round was led by Israeli private equity firm Shavit Capital and joined by global equity crowdfunding platform OurCrowd.com and Medison Pharma venture capital arm Medison Ventures, the Israel-based company said. The round was also joined by Apax Partner founds Ronald Cohen and Alan Patricof, Alpha Tau said. “We are confident that Alpha Tau’s ground-breaking technology can be a game changer in the treatment of cancer. Importantly, under the guidance of an exper...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Alpha Tau Medical Source Type: news

New nuclear medicine imaging method shows strong potential for cancer imaging
(Society of Nuclear Medicine and Molecular Imaging) A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 5, 2018 Category: International Medicine & Public Health Source Type: news

NIDCR Science News - August 2018
Having trouble viewing this email? View it as a Web page. How to Build a Cancer Many cancer researchers look for ways to stop the growth of cancer. J. Silvio Gutkind, PhD, is trying a different angle. He aims to piece together the steps needed to build a cancer—specifically head and neck cancer. NIDCR • August 30, 2018   Molecular Factors Underlie Mouth's Head Start on HealingNIH / I Am Intramural Blog • August 14, 2018 STAY CONNECTED ...
Source: NIDCR Science News - August 31, 2018 Category: Dentistry Source Type: news

UA Cancer Biology graduate student travels ROCKy ™ road toward a cure
(University of Arizona Health Sciences) The Limesand Lab at the University of Arizona is devoted to improving quality of life for head-and-neck cancer survivors, who often suffer from irreversible dry mouth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 30, 2018 Category: Cancer & Oncology Source Type: news

How Does Treatment Affect the Sexuality of Head and Neck Cancer Patients?
For patients undergoing primary treatment for head and neck cancer, sexuality was significantly impacted in many patients both prior to and during cancer treatment. (Source: CancerNetwork)
Source: CancerNetwork - August 27, 2018 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Novel Agent Dramatically Cuts Oral Mucositis After Radiation Novel Agent Dramatically Cuts Oral Mucositis After Radiation
A first-in-class synthetic superoxide dismutase dramatically reduced the duration of oral mucositis in patients with head and neck cancer receiving radiation therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cetuximab Failure in HPV+ Head and Neck Cancer
(MedPage Today) -- Inferior survival when paired with radiation therapy (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 16, 2018 Category: American Health Source Type: news

Marijuana May Improve Quality of Life in Head and Neck Cancer
Some significant benefits observed in quality of life domains for patients with newly diagnosed HNC (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 15, 2018 Category: Psychiatry Tags: Oncology, ENT, Psychiatry, Anesthesiology & amp; Pain, Journal, Source Type: news

Marijuana May Improve Quality of Life in Head and Neck Cancer
WEDNESDAY, Aug. 15, 2018 -- For patients with newly diagnosed head and neck cancer (HNC), quality of life may improve with marijuana use, according to a study published online Aug. 2 in JAMA Otolaryngology-Head& Neck Surgery. Han Zhang, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2018 Category: Pharmaceuticals Source Type: news

Robots An Increasing Presence In Maine Operating Rooms
Robots now assist surgeons with kidney cancer, difficult hernias and gynecologic cancers. Robot-assisted surgeries have the best outcomes and are most justified for hard-to-reach areas of the body, such as for prostate removal and head and neck surgeries, according to a 2016 study published in The Milbank Quarterly, a scholarly journal.08/14/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 14, 2018 Category: Urology & Nephrology Source Type: news

Clinical trial suggests new direction for heavy-smoking head and neck cancer patients
(University of Colorado Anschutz Medical Campus) Phase I results of olaparib with cetuximab and radiation led to 72 percent 2-year survival in 16 patients on trial, compared with an expected 2-year survival rate of about 55 percent for standard-of-care treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2018 Category: International Medicine & Public Health Source Type: news

Marijuana Use Tied to Less Pain/Anxiety in Head and Neck Cancer Marijuana Use Tied to Less Pain/Anxiety in Head and Neck Cancer
Patients with newly diagnosed head and neck cancer who used marijuana reported strikingly less pain and anxiety than well-matched nonusers. They also reported a greater sense of well-being.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Scientist Seeks Solutions for Cancer Patients with Dry Mouth
For several years, Wilmot Cancer Institute scientist Catherine Ovitt, Ph.D., has been investigating ways to protect and regenerate the salivary gland, which can be damaged during radiation treatment for head and neck cancer. Her lab ’s latest study focuses on the cells that secrete saliva — discovering the ways in which several different cell populations have the potential to restore salivary gland function. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - August 8, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Early trauma may be risk factor for anxiety and depression in adults with head/neck cancer
(Wiley) Among individuals with head and neck cancer (HNC), those who experienced childhood trauma were more likely to have advanced cancer, to have higher alcohol consumption, and to experience symptoms of anxiety and depression. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that childhood trauma history should be considered during treatment for HNC. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Cannabis Tied to QOL Benefits in Head and Neck Cancer
(MedPage Today) -- Patients on marijuana reported better depression and anxiety scores (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 3, 2018 Category: Hematology Source Type: news

Can New Algorithm Shed Light on Treatment Resistance in Head and Neck Cancer?
The CoGAPS gene activity algorithm may elucidate molecular changes that occur as H&N tumors acquire resistance to cetuximab, says a Johns Hopkins team. (Source: CancerNetwork)
Source: CancerNetwork - July 30, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Second Primary Malignancy Risk Doubled After Head and Neck Cancer Second Primary Malignancy Risk Doubled After Head and Neck Cancer
The risk of second primary malignant neoplasm (SPMN) doubles after a first head and neck squamous cell carcinoma (HNSCC), especially when the site of the first cancer is not typically associated with malignancies due to human papillomavirus (HPV), according to a retrospective study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 27, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FLT-PET points toward survival for glioblastoma patients
PET scans with the radiotracer F-18 fluorothymidine (FLT) can help determine...Read more on AuntMinnie.comRelated Reading: SNMMI: PET, MRI may predict pediatric brain tumor outcomes FDG-PET/CT beats FLT-PET/CT for differentiated thyroid cancer FLT-PET could help predict outcome in head and neck cancer JNM: FLT-PET aids prognosis of glioma patients FLT-PET helps predicts cancer therapy results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 26, 2018 Category: Radiology Source Type: news

Curcumin suppresses growth of head and neck cancers
(Natural News) As terrifying as any cancer diagnosis is, hearing that one has head or neck cancer can be especially frightening. Knowing that cancer is lurking close to the brain is ominous indeed, and many patients would immediately turn to chemotherapy and other conventional cancer treatments to try to fight the disease. Nonetheless, overall, such... (Source: NaturalNews.com)
Source: NaturalNews.com - July 24, 2018 Category: Consumer Health News Source Type: news

Pazopanib/Cetuximab Combo Promising in Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma
A Washington University School of Medicine team ’s findings might inform future research into inhibitors of angiogenesis and PD-1 in head and neck cancer. (Source: CancerNetwork)
Source: CancerNetwork - July 23, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Mesothelioma Case Report Touts Success with Opdivo
Not every mesothelioma patient benefits from the immunotherapy drug Opdivo, but for the ones that do, the response can be lifesaving. Opdivo, known generically as nivolumab, continues to produce dramatic results, inching it closer to FDA approval for mesothelioma cancer. A recently published individual case report describes “an exceptional and sustained response.” Treatment with Opdivo allowed one patient to go from a downward spiral, with only weeks to live, back into the workforce. “We were blown away by the patient’s response,” lead author Riley Jones, now in his fellowship at the Universit...
Source: Asbestos and Mesothelioma News - July 23, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Medical News Today: Signs and symptoms of medullary thyroid cancer
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer. The earliest sign of MTC is typically a painless lump in the neck. Later symptoms can include pain or discomfort, hoarseness, coughing, and difficulty swallowing or breathing. If caught early, the outlook for MTC is often very good. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 19, 2018 Category: Consumer Health News Tags: Head and Neck Cancer Source Type: news

Mayo Clinic Minute: The rise of HPV-related throat cancer
More than three quarters of Americans will get HPV at some point in their lives. Most will never know it because they'll show no symptoms. But Dr. Eric Moore, a Mayo Clinic head and neck surgeon, says a growing number of people are developing HPV-related throat cancer. And he fears the numbers are going to [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 18, 2018 Category: Databases & Libraries Source Type: news

Adjust Expectations Before Multi-Flap Reconstruction for Head and Neck Cancer Adjust Expectations Before Multi-Flap Reconstruction for Head and Neck Cancer
Surgeons should weigh the curative potential, as well as functional and aesthetic outcomes and costs, before undertaking complex, multi-flap reconstructions in head and neck cancer patients, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 13, 2018 Category: Surgery Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news

Child cancer drug approved for NHS use
60% of children with high-risk neuroblastoma can be treated with dinutuximab beta Related items fromOnMedica One in 10 children in phase I cancer trials respond to drugs Children need access to cancer drug ‘goldmine’ NICE rejects adjuvant use of breast cancer drug New breast cancer drug ‘unaffordable’ for NHS Drug could double head and neck cancer survival (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 12, 2018 Category: UK Health Source Type: news

Research Reveals Immunotherapy More Effective in Men
For mesothelioma patients, immunotherapy is mostly available through clinical trials at this time. Immunotherapy is a relatively new way to treat cancer, and doctors still are learning who will respond best to these novel therapies. Newly released medical research has found men seem to respond better to immunotherapy than women. But this doesn’t mean immunotherapy is off the table for women with mesothelioma. You should learn all you can about how immunotherapy works, why it may or may not be right for you and how you can best prepare yourself if you decide an immunotherapy clinical trial is right for you. Thorough ...
Source: Asbestos and Mesothelioma News - July 3, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Computer algorithm maps cancer resistance to drugs, therapy
(Johns Hopkins Medicine) New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 2, 2018 Category: International Medicine & Public Health Source Type: news

Anti-mucositis gel developed at UGR to be widely available by 2022
(University of Granada) Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients. The melatonin compound, in the form of a gel, has now passed phases 1 and 2 of clinical trials and is expected to be on sale by 2022. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news

New treatment may reverse drug resistance in mouth, neck cancers
A drug being tested for use against several cancers was found to be effective at reversing drug resistance in head and neck skin cancers, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 28, 2018 Category: Consumer Health News Source Type: news

CEL-SCI wins $2.9M in CRO legal battle
Score one for the little guy. After a four-year legal battle, immunotherapy maker CEL-SCI Corporation has won the first-ever breach-of-contract case against a contract research organization, or CRO. In a final and binding decision, an arbitrator concluded that CRO inVentiv knowingly and fraudulently misled CEL-SCI with regard to enrollment projections for a clinical trial of CEL-SCI’s immunotherapy treatment for head and neck cancer. The arbitrator also said inVentiv used “scorched earth” litigation tactics and awarded CEL-SCI $2.9 million in damages, according to a statement from Vienna, Va.-based C...
Source: Mass Device - June 27, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Legal News Oncology Research & Development cel-sci inVentiv Source Type: news

New diagnosis method could help spot head and neck cancers earlier
(IOP Publishing) Oral squamous cell carcinomas (OSCCs) are the most common head and neck cancers, but are often diagnosed late.Now, researchers in Germany have developed a new cell-based test that could help provide earlier and more reliable diagnosis of OSCCs.Writing in Convergent Science Physical Oncology, the researchers explain how they tested the mechanical properties of OSCC cells, and found they were 'softer' than benign cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation th...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news

Success of dental implants after head and neck radiation therapy?
What are the factors potentially influencing the success of dental implants placed in patients with head and neck cancer who underwent radiation therapy?The postSuccess of dental implants after head and neck radiation therapy? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 21, 2018 Category: Dentistry Authors: osseonews Tags: Research and News Surgical Source Type: news

A Better Regimen for Head and Neck Cancer?
(MedPage Today) -- Study backs combo of chemotherapy, cetuximab, and radiotherapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 13, 2018 Category: Hematology Source Type: news

Factors associated with increased risk of suicide among survivors of head and neck cancer: a population-based analysis - Osazuwa-Peters N, Arnold LD, Loux TM, Varvares MA, Schootman M.
OBJECTIVES: Cancer diagnosis is considered an independent predictor of suicide. We aimed to determine whether gender and human papillomavirus (HPV)-relatedness are associated with increased risks of suicide in the head and neck cancer (HNC) population. ... (Source: SafetyLit)
Source: SafetyLit - June 12, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Prevalence and risk factors of suicidal ideation among patients with head and neck cancer: longitudinal study - Henry M, Rosberger Z, Bertrand L, Klassen C, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Black M, MacDonald C, Zhang X, Chartier G, Frenkiel S.
OBJECTIVEs (1) Determine 1-year period prevalence of suicidal ideation, suicide attempt, and completed suicide among patients newly diagnosed with a first occurrence of head and neck cancer (HNC). (2) Characterize stability and trajectory of suicidal ideat... (Source: SafetyLit)
Source: SafetyLit - June 11, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

ASCO: Undertreatment Seen for Women With Head & amp; Neck Cancer
THURSDAY, June 7, 2018 -- Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news

Melatonin Gel May Reduce Oral Mucositis From Chemo, Radiation Melatonin Gel May Reduce Oral Mucositis From Chemo, Radiation
Data from a phase II trial of Mucomel (3% melatonin gel) suggest the formulation may reduce the risk of oral mucositis resulting from chemo and radiotherapy for head and neck cancers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 6, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Colorado study suggests new combination treatment against relapsed head and neck cancer
(University of Colorado Anschutz Medical Campus) 'EphB4-ephrin-B2 inhibitors are currently in clinical trials in other disease settings, and our work shows that it might be successful in combination with EGFR inhibition in advanced head and neck cancers as well,' says Sana Karam, M.D., Ph.D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2018 Category: International Medicine & Public Health Source Type: news